Maitri Enterprises reports standalone net profit of Rs 0.02 crore in the March 2022 quarter

Maitri Enterprises standalone net profit rises 450.00% in the September 2021 quarter

Hasn't fared well - amongst the low performers

Seems to be overvalued vs the market average

Lagging behind the market in financials growth

Average profitability - not good, not bad

Good time to consider, stock is not in the overbought zone

The stock has a moderate number of red flags

Maitri Enterprises is engaged in trading of pharmaceutical and medical goods.

With a market cap of ₹12 cr, stock is ranked 4,469